Drug class
Antithrombin Agents
Antithrombin agents encompass therapeutic formulations of antithrombin—a naturally occurring plasma glycoprotein and serine protease inhibitor—as well as direct antithrombin or thrombin-inhibiting therapies. Read more about Antithrombin Agents
164 drugs in this class 74 manufacturers
Drugs in Antithrombin Agents
AA 3%-D5W-LOW CALCIUM-HEPARIN (amino acid 3 % comb no.2(pedi)/D5W/calcium gluconate/heparin)
AA 3.5%-D10W-LO CALCIUM-HEPARN (amino acid 3.5 % no.2 ped/dextrose 10 %/calcium gluc/heparin)
Antithrombin agents encompass therapeutic formulations of antithrombin—a naturally occurring plasma glycoprotein and serine protease inhibitor—as well as direct antithrombin or thrombin-inhibiting therapies.
In therapeutic replacement, these agents function by binding to and inactivating thrombin and other activated clotting factors (such as factor Xa), a process markedly accelerated by heparin, thereby dampening the coagulation cascade and preventing thrombus formation.
In clinical pharmacology, they are primarily indicated for the treatment and prophylaxis of thromboembolism—particularly peri-operative and peri-partum venous thromboembolic events—in patients with hereditary antithrombin deficiency, and broadly serve as antithrombotic therapies across specialized thromboembolic disorders.
-
fda.gov
Antithrombin agents encompass therapeutic formulations of antithrombin—a naturally occurring plasma glycoprotein and serine protease inhibitor—as well as direct antithrombin or thrombin-inhibiting therapies In clinical pharmacology, they are primarily indicated for the treatment and prophylaxis of thromboembolism—particularly peri-operative and peri-partum venous thromboembolic events—in patients with hereditary antithrombin deficiency, and broadly serve as antithrombotic therapies across specia...
-
nih.gov
Antithrombin agents encompass therapeutic formulations of antithrombin—a naturally occurring plasma glycoprotein and serine protease inhibitor—as well as direct antithrombin or thrombin-inhibiting therapies In clinical pharmacology, they are primarily indicated for the treatment and prophylaxis of thromboembolism—particularly peri-operative and peri-partum venous thromboembolic events—in patients with hereditary antithrombin deficiency, and broadly serve as antithrombotic therapies across specia...
-
nih.gov
Antithrombin agents encompass therapeutic formulations of antithrombin—a naturally occurring plasma glycoprotein and serine protease inhibitor—as well as direct antithrombin or thrombin-inhibiting therapies In therapeutic replacement, these agents function by binding to and inactivating thrombin and other activated clotting factors (such as factor Xa), a process markedly accelerated by heparin, thereby dampening the coagulation cascade and preventing thrombus formation
-
fda.gov
In therapeutic replacement, these agents function by binding to and inactivating thrombin and other activated clotting factors (such as factor Xa), a process markedly accelerated by heparin, thereby dampening the coagulation cascade and preventing thrombus formation
-
drugbank.com
In therapeutic replacement, these agents function by binding to and inactivating thrombin and other activated clotting factors (such as factor Xa), a process markedly accelerated by heparin, thereby dampening the coagulation cascade and preventing thrombus formation
-
fda.gov
In clinical pharmacology, they are primarily indicated for the treatment and prophylaxis of thromboembolism—particularly peri-operative and peri-partum venous thromboembolic events—in patients with hereditary antithrombin deficiency, and broadly serve as antithrombotic therapies across specialized thromboembolic disorders
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.